Revolizer Device

revolizer
revolizer Device is useful for inhaling dry medication powder orally for treating lung-related diseases. it is a cost-effective, simple to use, and environmentally friendly device for pulmonary (lung-related) drug delivery. revolizer inhaler helps in controlling and treating asthma by providing accurate dosing and excellent delivery of the drug in the lungs.

Features of Revolizer Device:
Easy to use: Requires the placement of a drug capsule and inhalation through the mouthpiece provided, without shaking or priming.
Easy to maintain: The capsule chamber and the mouthpiece of the asthma device are cleaned with a dry, clean cloth.
Portable: This COPD device is small in size and can be carried around to deliver drug anywhere as needed.
Accurate and consistent dosage: The drug capsule provides fixed amount of the medication.

Use under medical supervision.

Revolizer device Machine is designed and developed to address the critical requirements of an ideal inhalation device. It provides accurate dosing and excellent lung deposition and is very easy to use and maintain.

Key Benefits

• Easy to learn how to use.
• Accurate, consistent, and effective in medication delivery.
• Portable.

Directions for Use

Read the enclosed instruction manual before use.

Safety Information

Must clean once a week.
Read the label carefully before use.

Treatment

Inhaling dry powder orally for treating lung-related diseases

Context:
While prescribing an inhaler device, it is important to take into account the usability, preference, confidence, and satisfaction of the patients.

Aims:

The present study assessed these parameters with Revolizer®, a novel dry powder inhaler (DPI), in patients with obstructive airway diseases and in device-naïve healthy participants.

Settings and Design:
In this open-label, prospective, multicentre study with 100 participants [n = 50 healthy participants, n = 45 mild asthma patients, and n = 5 mild chronic obstructive pulmonary disease (COPD) patients], all participants were instructed and trained on the use of Revolizer and then the participants subsequently demonstrated the inhalation technique at two visits.

Materials and Methods:
The average time required to execute three correct consecutive attempts and the number of errors (including critical errors) were recorded. Participants were asked about the ease of use, preference, confidence, and satisfaction by means of a questionnaire at each visit.

Results:

The average time required by the participants to achieve three correct consecutive attempts at visit 1 was 3.75 ± 2.10 min, which significantly reduced at visit 2 (3.07 ± 1.32 min, P < 0.01). The number of errors decreased from visit 1 to visit 2. More than 85% participants found the Revolizer easy to use, and it was preferred by more than 75% participants. Revolizer scored high on the confidence and satisfaction of all participants at both visits.

Conclusions:
Revolizer is an easy-to-use and a preferred device in patients with mild asthma and COPD, as well as in healthy participants with no previous experience of using inhalation devices. The participants felt confident and satisfied using the Revolizer.

click more: revolizer device

Additional information